Advertisement
Original Paper| Volume 32, ISSUE 4, P607-611, April 2016

Preliminary diagnostic reference levels for endoscopic retrograde cholangio-pancreatography in Greece

Published:April 08, 2016DOI:https://doi.org/10.1016/j.ejmp.2016.03.018

      Highlights

      • National preliminary DRLs for KAP and Tf, during ERCPs in Greece.
      • Determination of the relation between KAP and Tf.
      • Comparison of the results with past studies.

      Abstract

      The main objective of this study was to determine the preliminary Diagnostic Reference Levels (DRLs) in terms of Kerma Area Product (KAP) and fluoroscopy time (Tf) during Endoscopic Retrograde Cholangio-Pancreatography (ERCP) procedures. Additionally, an investigation was conducted to explore the statistical relation between KAP and Tf.
      Data from a set of 200 randomly selected patients treated in 4 large hospitals in Greece (50 patients per hospital) were analyzed in order to obtain preliminary DRLs for KAP and Tf during therapeutic ERCP procedures. Non-parametric statistic tests were performed in order to determine a statistically significant relation between KAP and Tf.
      The resulting third quartiles for KAP and Tf for hospitals (A, B, C and D) were found as followed: KAPA = 10.7 Gy cm2, TfA = 4.9 min; KAPB = 7.5 Gy cm2, TfB = 5.0 min; KAPC = 19.0 Gy cm2, TfC = 7.3 min; KAPD = 52.4 Gy cm2, TfD = 15.8 min. The third quartiles, calculated for the total 200 cases sample, are: KAP = 18.8 Gy cm2 and Tf = 8.2 min. For 3 out of 4 hospitals and for the total sample, p-values of statistical indices (correlation of KAP and Tf) are less than 0.001, while for the Hospital A p-values are ranging from 0.07 to 0.08. Using curve fitting, we finally determine that the relation of Tf and KAP is deriving from a power equation (KAP = Tf1.282) with R2 = 0.85.
      The suggested Preliminary DRLs (deriving from the third quartiles of the total sample) for Greece are: KAP = 19 Gy cm2 and Tf = 8 min, while the relation between KAP and Tf is efficiently described by a power equation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Physica Medica: European Journal of Medical Physics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tsapaki V.
        • Paraskeva K.D.
        • Mathou N.
        • Andrikopoulos E.
        • Tentas P.
        • Triantopoulou C.
        • Karagiannis J.A.
        Patient and endoscopist radiation doses during ERCP procedures.
        Radiat Prot Dosimetry. 2011; 147: 111-113
        • Tsalafoutas I.A.
        • Paraskeva K.D.
        • Yakoumakis E.N.
        • Vassilaki A.E.
        • Maniatis P.N.
        • Karagiannis J.A.
        • et al.
        Radiation doses to patients from endoscopic retrograde cholangiopancreatography examinations and image quality considerations.
        Radiat Prot Dosimetry. 2003; 106: 241-246
        • Larkin C.
        • Workman A.
        • Wright R.E.
        • Tham C.K.
        Radiation doses to patients during ERCP.
        Gastrointest Endosc. 2001; 53: 161-164
        • Olgar T.
        • Bor D.
        • Berkmen G.
        • Yazar T.
        Patient and staff doses for some complex x-ray examinations.
        J Radiol. 2009; 29: 393-407
        • Buls N.
        • Pages J.
        • Mana F.
        • Osteaux M.
        Patient and staff exposure during endoscopic retrograde cholangiopancreatography.
        Br J Radiol. 2002; 75: 435-443
        • Heyd R.L.
        • Kopecky K.K.
        • Sherman S.
        • Lehman G.A.
        • Stockberger S.M.
        Radiation exposure to patients and personnel during interventional ERCP at a teaching institution.
        Gastrointest Endosc. 1996; 44: 287-292
        • Cohen G.
        • Brodmerkel G.J.
        • Lynn S.
        Absorbed doses to patients and personnel from endoscopic retrograde cholangiopancreatographic (ERCP) examinations.
        Radiology. 1979; 130: 773-775
        • Dumonceau J.M.
        • Garcia-Fernandez F.J.
        • Verdun F.R.
        • Carinou E.
        • Donadille L.
        • Damilakis J.
        • et al.
        European Society of Gastrointestinal Endoscopy (ESGE) Guideline: radiation protection in digestive endoscopy.
        Endoscopy. 2012; 44: 408-424
        • Hart D.
        • Hillier M.
        • Wall B.
        Doses to Patients from Medical Examinations in the UK - 2000 Review.
        National Radiological Protection Board, 2002
      1. Patient dose optimization in fluoroscopically guided interventional procedures: Final report of a coordinated research project, IAEA-TECDOC-1641, International Atomic Energy Agency; 2010.

      2. ICRP Publication 103, The 2007 Recommendations of the International Commission on Radiological Protection, Ann. 2007; ICRP 37:2–4.

      3. Institute of Physical Sciences in Medicine, National Radiological Protection Board and College of Radiographers. National Protocol for patient dose measurements in diagnostic radiology. National Radiological protection Board, Chilton England; 1997.

        • Seo D.
        • Kim K.H.
        • Kim J.S.
        • Han S.
        • Park K.
        • Kim J.
        Evaluation of radiation doses in patient and medical staff during Endoscopic Retrograde Cholangiopancreatography procedures.
        Radiat Prot Dosimetry. 2015; : ncv373